AAAAAA

   
Results: 1-9 |
Results: 9
GLOEOLACTONE, A NEW EPOXY LACTONE FROM A BLUE-GREEN-ALGA
Authors: STIERLE DB STIERLE AA BUGNI T LOEWEN G
Citation: Db. Stierle et al., GLOEOLACTONE, A NEW EPOXY LACTONE FROM A BLUE-GREEN-ALGA, Journal of natural products, 61(2), 1998, pp. 251-252
UNUSUAL CENTRAL-NERVOUS-SYSTEM TOXICITY IN A PHASE-I STUDY OF N(1)N(11)DIETHYLNORSPERMINE IN PATIENTS WITH ADVANCED MALIGNANCY
Authors: CREAVEN PJ PEREZ R PENDYALA L MEROPOL NJ LOEWEN G LEVINE E BERGHORN E RAGHAVAN D
Citation: Pj. Creaven et al., UNUSUAL CENTRAL-NERVOUS-SYSTEM TOXICITY IN A PHASE-I STUDY OF N(1)N(11)DIETHYLNORSPERMINE IN PATIENTS WITH ADVANCED MALIGNANCY, Investigational new drugs, 15(3), 1997, pp. 227-234
PACLITAXEL AND CARBOPLATIN IN EARLY PHASE STUDIES - ROSWELL-PARK-CANCER-INSTITUTE EXPERIENCE IN THE SUBSET OF PATIENTS WITH LUNG-CANCER
Authors: CREAVEN PJ RAGHAVAN D PENDYALA L LOEWEN G KINDLER HL BERGHORN EJ
Citation: Pj. Creaven et al., PACLITAXEL AND CARBOPLATIN IN EARLY PHASE STUDIES - ROSWELL-PARK-CANCER-INSTITUTE EXPERIENCE IN THE SUBSET OF PATIENTS WITH LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 138-143
EARLY PHASE STUDIES WITH PACLITAXEL LOW-DOSE CARBOPLATIN IN PATIENTS WITH SOLID TUMORS/
Authors: CREAVEN PJ RAGHAVAN D PEREZ RP PENDYALA L BERGHORN EJ LOEWEN G MEROPOL NJ
Citation: Pj. Creaven et al., EARLY PHASE STUDIES WITH PACLITAXEL LOW-DOSE CARBOPLATIN IN PATIENTS WITH SOLID TUMORS/, Seminars in oncology, 23(6), 1996, pp. 26-31
CARDIAC-HYPERTROPHY IN RATS AFTER INTRAVENOUS ADMINISTRATION OF CI-959, A NOVEL ANTIINFLAMMATORY COMPOUND - MORPHOLOGIC FEATURES AND PHARMACOKINETIC AND PHARMACODYNAMIC MECHANISMS
Authors: LOW JE METZ AL MERTZ TE HENRY SP KNOWLTON P LOEWEN G SOMMERS CS ROBERTSON DG OLSZEWSKI BJ SCHROEDER RL GOUGH AW KEISER J MANN D
Citation: Je. Low et al., CARDIAC-HYPERTROPHY IN RATS AFTER INTRAVENOUS ADMINISTRATION OF CI-959, A NOVEL ANTIINFLAMMATORY COMPOUND - MORPHOLOGIC FEATURES AND PHARMACOKINETIC AND PHARMACODYNAMIC MECHANISMS, Journal of cardiovascular pharmacology, 25(6), 1995, pp. 930-939
PHASE-I STUDY OF PACLITAXEL AND CARBOPLATIN - IMPLICATIONS FOR TRIALSIN HEAD AND NECK-CANCER
Authors: CREAVEN P RAGHAVAN D PENDYALA L PEREZ R LOEWEN G MEROPOL N LEVINE E HICKS W
Citation: P. Creaven et al., PHASE-I STUDY OF PACLITAXEL AND CARBOPLATIN - IMPLICATIONS FOR TRIALSIN HEAD AND NECK-CANCER, Seminars in oncology, 22(5), 1995, pp. 13-16
CARBOPLATIN FOR SMALL-CELL LUNG-CANCER - PROGRESS TOWARD GREATER EFFICACY AND REDUCED TOXICITY
Authors: RAGHAVAN D PEREZ R CREAVEN P TAKITA H LOEWEN G VAICKUS L
Citation: D. Raghavan et al., CARBOPLATIN FOR SMALL-CELL LUNG-CANCER - PROGRESS TOWARD GREATER EFFICACY AND REDUCED TOXICITY, Seminars in oncology, 21(3), 1994, pp. 1-8
SUBACUTE AND SUBCHRONIC TOXICOLOGY STUDIES OF CI-986, A NOVEL ANTIINFLAMMATORY COMPOUND
Authors: ROBERTSON DG LOEWEN G WALSH KM DETHLOFF LA SIGLER RS DOMINICK MA URDA ER
Citation: Dg. Robertson et al., SUBACUTE AND SUBCHRONIC TOXICOLOGY STUDIES OF CI-986, A NOVEL ANTIINFLAMMATORY COMPOUND, Fundamental and applied toxicology, 20(4), 1993, pp. 446-455
SAFETY AND TOLERANCE OF INTRAMUSCULAR ADMINISTRATION OF FOSPHENYTOIN,A PHENYTOIN PRODRUG, FOR 5 DAYS IN PATIENTS WITH EPILEPSY
Authors: WILDER BJ RAMSAY E MARRIOTT J LOEWEN G SMITH H
Citation: Bj. Wilder et al., SAFETY AND TOLERANCE OF INTRAMUSCULAR ADMINISTRATION OF FOSPHENYTOIN,A PHENYTOIN PRODRUG, FOR 5 DAYS IN PATIENTS WITH EPILEPSY, Neurology, 43(4), 1993, pp. 308-308
Risultati: 1-9 |